Trials that use: Factorial design
New to this method? Read the tutorial →
153 results
- (RISE)Independent statistical analysis of Research and Innovation to Stop E-cigarette/Vaping in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04974580).
- 1565GCCIndependent statistical analysis of Decitabine and Talazoparib in Untreated AML and R/R AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02878785).
- 3CIndependent statistical analysis of Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01120028).
- A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals’ Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su)…
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart: Complete Statistical AnalysisIndependent statistical analysis of A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had…
- A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00384865).
- A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians: Complete Statistical AnalysisIndependent statistical analysis of A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AASKA statistical analysis of the AASK phase 3 trial evaluating blood pressure targets and antihypertensive strategies in African American patients with hypertensive nephrosclerosis and chronic renal insufficiency.
- Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00585559).
- ACTG 388An independent statistical analysis of ACTG 388, a randomized factorial trial evaluating simplified drug regimens in patients with HIV infection. The page explains the factorial design, planned statistical framework, endpoints reported in…
- Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: Complete Statistical AnalysisIndependent statistical analysis of Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01197950).
- Acute and Residual Effects of Caffeinated Beer: Complete Statistical AnalysisIndependent statistical analysis of Acute and Residual Effects of Caffeinated Beer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515294).
- Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.: Complete Statistical AnalysisIndependent statistical analysis of Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04611529).
- ADVANCEIndependent statistical analysis of the ADVANCE phase 3 trial of blood pressure and glucose lowering for prevention of vascular disease in high-risk patients with type 2 diabetes, including its factorial design, composite…
- APOGEEIndependent statistical analysis of Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01892501).
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A): Complete Statistical AnalysisIndependent statistical analysis of Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Behavioral Economic Treatment to Enhance Rural (BETTER) Living: Complete Statistical AnalysisIndependent statistical analysis of Behavioral Economic Treatment to Enhance Rural (BETTER) Living: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05235971).
- BingocizeIndependent statistical analysis of Bingocize: A Novel Mobile Application for Older Adult Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03629912).
- BLSPilotIndependent statistical analysis of Three Different Cardiopulmonary Resuscitation (CPR) Training Methods: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01361919).
- BODY-REALIndependent statistical analysis of Clinical Effectiveness of Body Fat Distribution Imaging in Real-World Practice: The BODY-REAL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BWP-ADIndependent statistical analysis of Enhancing Consent for Alzheimer's Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00453544).
- Cangrelor Ticagrelor Transition Study: Complete Statistical AnalysisIndependent statistical analysis of Cangrelor Ticagrelor Transition Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01766466).
- CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CGDNIndependent statistical analysis of N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265563).
- CHEERIndependent statistical analysis of Community Health Through Engagement and Environmental Renewal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04362475).
- Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CHIVESIndependent statistical analysis of Designing Food Voucher Programs to Reduce Disparities in Healthy Diets: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02843178).
- Chronic Sleep Deprivation Among the Poor: A Lab-in-the-field Approach: Complete Statistical AnalysisIndependent statistical analysis of Chronic Sleep Deprivation Among the Poor: A Lab-in-the-field Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03322358).
- Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM): Complete Statistical AnalysisIndependent statistical analysis of Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cigarette Pack Inserts for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Cigarette Pack Inserts for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04075682).
- Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CLEAR SYNERGYIndependent statistical analysis of CLEAR SYNERGY, a randomized phase 3 factorial trial evaluating colchicine and spironolactone strategies in patients with ST elevation or non-ST elevation myocardial infarction, including its primary endpoints, trial…
- Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home: Complete Statistical AnalysisIndependent statistical analysis of Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- COMMIT-CCS-2An educational statistical analysis of COMMIT-CCS-2, a randomized, double-blind, factorial phase 4 trial evaluating clopidogrel and metoprolol in acute myocardial infarction, with emphasis on factorial design and its primary endpoints.
- Contact: Developing New Clinical Management Strategies: Complete Statistical AnalysisIndependent statistical analysis of Contact: Developing New Clinical Management Strategies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03812588).
- CONTAINIndependent statistical analysis of Inhaled Ciclesonide for Outpatients With COVID19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04435795).
- COSMOS-MindIndependent statistical analysis of COcoa Supplement and Multivitamin Outcomes Study for the Mind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03035201).
- CSISP-MENC1Independent statistical analysis of Immunogenicity of the Booster Dose of Two MenC Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00392808).
- DEFINEIndependent statistical analysis of Endophenotype for Alcohol Misuse in Healthy Minority Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00256451).
- DESKTOP IIIAn independent statistical analysis of DESKTOP III, a randomized study comparing tumor debulking surgery versus chemotherapy alone in recurrent platinum-sensitive ovarian cancer.
- Developing E-liquid Product Standards (Sweet Spot Study): Complete Statistical AnalysisIndependent statistical analysis of Developing E-liquid Product Standards (Sweet Spot Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05864586).
- Dietary Assessment Study Via Digital Images: Complete Statistical AnalysisIndependent statistical analysis of Dietary Assessment Study Via Digital Images: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03267004).
- DietGERDIndependent statistical analysis of Dietary Carbohydrate and GERD in Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02384551).
- Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05325944).
- Effect of Lidocaine and Esmolol to Improve the Quality of Recovery: Complete Statistical AnalysisIndependent statistical analysis of Effect of Lidocaine and Esmolol to Improve the Quality of Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility – 1: Complete Statistical AnalysisIndependent statistical analysis of Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Effects of Broccoli Sprout Extract on Allergy Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of Effects of Broccoli Sprout Extract on Allergy Rhinitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02885025).